Sika Interplant Systems Limited has announced that a meeting of its Board of Directors is scheduled to be held on Friday, 8 May 2026. The meeting has been convened pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda for the Board Meeting

The board will consider two primary items during the meeting. First, it will consider and approve the audited standalone and consolidated financial results of the company for the quarter and financial year ended 31 March 2026. Second, the board will consider the recommendation of a final dividend to the shareholders for the financial year ended 31 March 2026.

Trading Window Closure

The company has informed that the trading window for designated persons has been closed since 1 April 2026. This window will reopen 48 hours after the conclusion of the board meeting scheduled on 8 May 2026, in accordance with regulatory requirements.

Key Details

The intimation was signed by Suraj Kumar Sahu, Company Secretary & Compliance Officer of Sika Interplant Systems Limited, on 30 April 2026.

Sika Interplant Systems Limited has submitted its mandatory compliance certificate to BSE Limited under SEBI regulations for the March 2026 period. The filing demonstrates the company's adherence to regulatory requirements governing share transfer and dematerialisation processes.

Regulatory Compliance Certificate

The company filed a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 covering the period from 01.03.2026 to 31.03.2026. Company Secretary and Compliance Officer Suraj Kumar Sahu submitted the documentation to BSE Limited on 14th April 2026.

Share Transfer Agent Confirmation

Integrated Registry Management Services Private Limited, serving as the company's registrar and share transfer agent, issued the compliance certificate on 6th April 2026. General Manager S Giridhar confirmed that the agency received no requests for dematerialisation or rematerialisation of shares during the specified period.

The certificate specifically states: "we hereby confirm that we have not received any request for dematerialisation or rematerialisation of shares for the period 01.03.2026 to 31.03.2026."

Corporate Information

Sika Interplant Systems Limited maintains its registered office at No 03 Gangadhar Chetty Road, Dr. Sharma Building, Bangalore – 560 042. The company's shares are listed on BSE with scrip code 523606 and ISIN INE438E01032.

Integrated Registry Management Services Private Limited operates from Bangalore with its registered office in Chennai. The agency holds SEBI registration number INR000000544 and provides both share-related and fixed deposit services to corporate clients.